Risk of coronary artery disease and stroke according to sex and presence of diabetic nephropathy in type 1 diabetes
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Aims: To determine the effect of different stages of diabetic nephropathy (DN) and sex on the excess and absolute morbidity of coronary artery disease (CAD) and stroke in people with type 1 diabetes (T1D) in order to distinguish different cardiovascular disease (CVD) risk profiles in people with T1D. Materials and Methods: The study included 4410 people with T1D from the Finnish Diabetic Nephropathy Study (FinnDiane), divided by DN status, and a control population of 12 434 people without diabetes. CVD events were identified from the Finnish nationwide health registries. Cumulative incidences for CAD and stroke were calculated and standardized incidence ratios (SIRs) were estimated between participants with T1D and the control group, stratified by DN status and sex. Results: There were 487 incident CADs and 290 strokes at the end of 2014 (median follow‐up 12.9 years). The cumulative incidence rates of CAD and stroke were similar in men and women within different nephropathy groups. The SIR for CAD was 7.5 (95% confidence interval [CI] 6.9‐8.2), 17.2 (95% CI 14.9‐19.5) in women and 5.3 (95% CI 4.7‐5.9) in men. The women‐to‐men ratio of SIR increased by nephropathy group: 3.3, 3.7, 5.3 and 6.8 in the normo‐, micro‐ and macroalbuminuria and end‐stage renal disease (ESRD) groups, respectively. The SIR for stroke was 5.0 (95% CI 4.3‐5.5), similar in men and women. The women‐to‐men ratio of SIR for stroke was 0.8, 1.3, 1.6 and 1.7, in the normo‐, micro‐ and macroalbuminuria and ESRD groups, respectively. The SIR in participants with normoalbuminuria and an estimated glomerular filtration rate ≥90 mL/min/1.73 m 2 was 3.5 (95% CI 2.5‐4.5) for CAD and 1.6 (95% CI 1.0‐2.3) for stroke. Conclusions: Although the excess CVD risk is several‐fold greater in women compared to men, the absolute CVD risk in men and women was equal when nephropathy was taken into account. Even participants with normoalbuminuria and normal kidney function were found to have an excess CVD risk compared with the control group without diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nathan, D. M., & for the DCCT/EDIC Research Group (2014) · Diabetes Care · doi:10.2337/dc13-2112 · Cited by 1,832
Albuminuria reflects widespread vascular damage: The Steno hypothesis
Deckert, T., Feldt-Rasmussen, B., Borch-Johnsen, K., Jensen, T., & Kofoed-Enevoldsen, A. (1989) · Diabetologia · doi:10.1007/bf00285287 · Cited by 1,400
Glycemic Control and Excess Mortality in Type 1 Diabetes
Lind, M., Svensson, A.-M., Kosiborod, M., Gudbjörnsdottir, S., Pivodic, A., Wedel, H., Dahlqvist, S., Clements, M., & Rosengren, A. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1408214 · Cited by 964 · cited 7×
“It is of utmost importance to prevent the development of DN in order to prevent CVD. Kidney disease does not explain all the excess CVD risk, however, as the SIRs in the participants with normoalbuminuria and normal kidney function were also increased; therefore, the identification of specific risk factors related to…”
BackgroundInfluentialMortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes
Laing, S. P., Swerdlow, A. J., Slater, S. D., Burden, A. C., Morris, A., Waugh, N. R., Gatling, W., Bingley, P. J., & Patterson, C. C. (2003) · Diabetologia · doi:10.1007/s00125-003-1116-6 · Cited by 724 · cited 1×
“The magnitude of the excess risk, however, varies depending on the characteristics of the patients being studied, including age at diagnosis, duration of diabetes, attained age, presence and severity of other diabetic complications at enrolment, as well as the time period during which the study was conducted.(1,3) Rec…”
BackgroundThe presence and severity of chronic kidney disease predicts all-cause mortality in type 1 diabetes
Groop, P.-H., Thomas, M. C., Moran, J. L., Wadèn, J., Thorn, L. M., Mäkinen, V.-P., Rosengård-Bärlund, M., Saraheimo, M., Hietala, K., Heikkilä, O., et al. (2009) · Diabetes · doi:10.2337/db08-1543 · Cited by 638
Self-citationRisk Factors for Cardiovascular Disease in Type 1 Diabetes
The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Research Group (2016) · Diabetes · doi:10.2337/db15-1517 · Cited by 209
Cited by
Harjutsalo, V., Pongrac Barlovic, D., & Groop, P.-H. (2021) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(21)00172-8 · Cited by 82
Self-citationThomas, M., Harjutsalo, V., Feodoroff, M., Forsblom, C., Gordin, D., & Groop, P.-H. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz003 · Cited by 30
Self-citationCardiovascular risk management in type 1 diabetes
Teoh, I. H., Elisaus, P., & Schofield, J. D. (2021) · Current Diabetes Reports · doi:10.1007/s11892-021-01400-9 · Cited by 15
Metadata
- Authors
- Harjutsalo, V., Thomas, M. C., Forsblom, C., Groop, P., & On Behalf of the FinnDiane Study Group
- Venue
- Diabetes, Obesity and Metabolism
- Publisher
- Wiley
- Published
- 2018-08-07
- Volume
- 20
- Issue
- 12
- Pages
- 2759-2767
- ISSN
- 1462-8902 (ISSN-L)
- 1463-1326
- OpenAlex
- W2810440463
- Cited by
- 53
- References
- 6
- FWCI
- 3.70
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Risk of coronary artery disease and stroke according to sex and presence of diabetic nephropathy in type 1 diabetes. https://app.cochat.ai/papers/10.1111/dom.13456
- The paper
- Harjutsalo, V., Thomas, M. C., Forsblom, C., Groop, P., & On Behalf of the FinnDiane Study Group. (2018). Risk of coronary artery disease and stroke according to sex and presence of diabetic nephropathy in type 1 diabetes. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.13456
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.